Company: LNAI
Filing Date: 2025-09-29
Form Type: 10-K
Source: 0001731122-25-001316
Chunk: 37

Company: Lunai Bioworks Inc.
Filing Date: 2025-09-29
Form: 10-K
Item: Item 1A
Chunk 37
---
 organizations (“CROs”), contract manufacturers,
suppliers, service providers, consultants, advisors and other third parties. Renovaro Cube and BioSymetrics also enter into confidentiality
and invention or patent assignment agreements with its employees and consultants, and reminds departing employees when they leave their
employment of their continuing confidentiality obligations. Renovaro Cube and BioSymetrics cannot guarantee that they have entered into
such agreements with each party that may have, or have had, access to trade secrets or proprietary technology and processes. Despite Renovaro
Cube’s and BioSymetrics’ efforts, any of these parties may breach the agreements and disclose our proprietary information,
including trade secrets, and we may not be able to obtain adequate remedies for such breaches. Enforcing a claim that a party illegally
disclosed or misappropriated a trade secret is difficult, expensive, and time-consuming, and the outcome is unpredictable. Some
courts outside the respective jurisdictions of BioSymetrics and Renovaro Cube are less willing or unwilling to protect trade secrets.
For example, in China, claims regarding infringement or misappropriation of trade secrets are difficult to prove, and consequently plaintiffs
are rarely successful in bringing these claims. If any of Renovaro Cube’s or BioSymetrics’ trade secrets were to be lawfully
obtained or independently developed by a competitor or other third party, Renovaro Cube and BioSymetrics would have no right to prevent
them from using that technology or information to compete with us. If any of Renovaro Cube’s or BioSymetrics’ trade secrets
were to be misappropriated by, disclosed to, or independently developed by a competitor or other third party, Renovaro Cube’s or
BioSymetrics’ competitive position could be materially and adversely harmed.

Renovaro
Cube and BioSymetrics have and may enter into collaboration, license, contract research and/or manufacturing relationships with contract
organizations that operate in certain countries that are at heightened risk of theft of technology,
data and intellectual property through direct intrusion by private parties or foreign actors, including those affiliated with or controlled
by state actors. Accordingly, Renovaro Cube’s and BioSymetrics’ efforts to protect and enforce their intellectual property
rights around the world may be inadequate to obtain a significant commercial advantage from the intellectual property that Renovaro Cube
and BioSymetrics develops or licenses, and we may be at heightened risk of losing proprietary intellectual property rights around the
world, including outside of such countries, to the extent such